15,630
+0.06%
Close of 9 Nov 2026, in KRW
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Korea United Pharm
Its shares trade on KRX under the ticker 033270.KS. It has been listed since 23 October 2007. In the fiscal year to 31 December 2025, it reported revenue of ₩288.76bn and net income of ₩38.31bn. At that date it held total assets of ₩519.49bn and shareholders' equity of ₩454.63bn.
KOREA UNITED PHARM, Inc. engages in the manufacture and distribution of pharmaceuticals and healthcare products. The company is headquartered in Sejong, Sejong. The company went IPO on 2007-10-23. INC. is a Korea-based company engaged in the manufacture and marketing of pharmaceuticals. The Company’s products include remedies for gastrointestinal system, cardiovascular, hematopoietic system, respiratory system, central nervous system, musculoskeletal system, endocrine and metabolic system, allergy and immune system, as well as anti-infectives, gynecological agents, vitamins, nutrition products, anticancer medicines and others. The company also provides active pharmaceutical ingredients (APIs) and various health food products. The firm distributes its products within domestic market and to overseas markets.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 23 Oct 2007
- Employees
- 896
- Website
- kup.co.kr ↗
Leadership
Pay as last reported
- Deok Yeong KangChief Executive Officer, Director, since 2007
- Hyeong Rae KimManaging Director, since 2008
- Won Tae JungManaging Director
- Gwi Ja KimManaging Director, since 2008
- Jin Ho ChoManaging Director, since 2008
- Yong Wu ChoAssistant Managing Director
- Oh Byeong GwonAssistant Managing Director
- Jang Yeon ChoNon-Executive Independent Director
- Bak GwonNon-Executive Independent Director
- Yeon Taek LeeNon-Executive Independent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Korea United Pharm Inc employs 896 full-time employees in Sejong, KR.
- The company manufactures and distributes pharmaceuticals across multiple systems including cardiovascular and gastrointestinal.
- Korea United Pharm Inc provides active pharmaceutical ingredients and health food products domestically and overseas.
Weaknesses
- Korea United Pharm Inc has no overseas manufacturing facilities mentioned in the facts.
- The company's products are limited to domestic and overseas distribution without specific market share data.
- Korea United Pharm Inc does not specify any R&D investments or new product development in the facts.
Opportunities
- Korea United Pharm Inc can expand its distribution of anti-infectives and anticancer medicines globally.
- The company can leverage its APIs to enter new markets in the Health Care sector.
- Korea United Pharm Inc can grow its health food product line in the domestic market.
Threats
- Korea United Pharm Inc faces competition from other KR-based pharmaceutical companies without specific names.
- The company's reliance on domestic market distribution may limit growth opportunities.
- Korea United Pharm Inc does not mention any regulatory changes affecting its operations.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.